PATHEON SOFTGELS
GenericsPATHEON SOFTGELS is a generic drug manufacturer focused on Immunology.
PATHEON SOFTGELS's Key Drugs
PATHEON SOFTGELS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PATHEON SOFTGELS's Recent FDA Approvals
New NDA/BLA approvals for PATHEON SOFTGELS over the last two years — novel drugs only, excluding generics and label supplements.
PATHEON SOFTGELS's Therapeutic Areas
PATHEON SOFTGELS's approved drugs and pipeline span 1 therapeutic area, led by Immunology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PATHEON SOFTGELS's Top Competitors
PATHEON SOFTGELS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PATHEON SOFTGELS Pipeline Snapshot
Active clinical trials for PATHEON SOFTGELS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2023-01-10
- Latest
- 2024-02-13
- Applications
- 2